Senator Bill Cassidy (R-La.) has signaled potential opposition to President-elect Donald Trump’s choice for FDA commissioner, Dr. Heidi Overton. As the incoming chair of the Senate Health, Education, Labor and Pensions Committee, Cassidy holds a pivotal role in the confirmation process. His primary objection centers on Overton’s previous professional involvement in a vaccine-related order issued during the Trump administration.

Cassidy stated that while he acknowledges Overton’s background as a physician, her specific role in that order is “almost disqualifying.” The Senator’s comments suggest that the confirmation process may face hurdles, as he is tasked with overseeing the committee that will vet the nominee. The Trump transition team has not yet issued a detailed rebuttal to Cassidy’s specific claim, though the nomination is expected to be a key focus of upcoming Senate hearings. The disagreement highlights a potential friction point between the incoming administration’s cabinet picks and key Republican lawmakers who oversee health policy.